SARS-CoV-2 Omicron

Zengchao Sun1, Lu Wang2, Lingyun Li3

  • 1Department of Biopharmaceutics, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China; State Key Laboratory of Drug Research, The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

概括

研究人员确定了针对SARS-CoV-2受体结合域的强有力的纳米体,为抗击Omicron变种和未来的COVID-19大流行提供了有前途的战略.